Beta-adrenoreceptor blocking properties of new thienylethanolamine derivatives.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000526:Alprenolol / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004837:Epinephrine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology* / Q000633:toxicity; D005260:Female; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic; D012032:Refractory Period, Electrophysiological / Q000187:drug effects; D012890:Sleep / Q000187:drug effects; D013876:Thiophenes / Q000494:pharmacology* / Q000633:toxicity
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D011941:Receptors, Adrenergic; D013876:Thiophenes; D006632:Histamine; D000526:Alprenolol; D011433:Propranolol; D007545:Isoproterenol; D004837:Epinephrine